Journal of Translational Critical Care Medicine,
Journal Year:
2024,
Volume and Issue:
6(4)
Published: Sept. 19, 2024
The
emergence
of
antimicrobial
resistance
(AMR)
represents
one
the
most
significant
global
public
health
threats,
imposing
substantial
economic
burdens.
To
address
this
critical
issue
resistance,
promising
alternative
strategies
for
treating
resistant
bacterial
infections
is
bacteriophage
therapy.
Bacteriophages
exhibit
high
specificity
towards
bacteria,
capable
lysing
and
killing
specific
strains.
Phage
cocktails
can
broaden
spectrum
activity,
contribute
to
target
multiple
types
bacteria.
Personalized
therapy,
tailored
individual
patients,
enhances
precise
targeting
pathogens.
Increasing
evidence
supports
feasibility
phage-antibiotic
combinations
in
multidrug-resistant
Furthermore,
genetic
engineering,
including
technologies
like
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)-Cas,
has
advanced
development
engineering
phages,
providing
novel
ways
kill
hosts.
This
review
discusses
research
progress
refractory
caused
by
advantages
limitations
phage
highlights
clinical
studies
case
reports
various
treatment
modalities.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 7, 2025
Introduction
Hypervirulent
and
multidrug-resistant
Klebsiella
pneumoniae
(hvKP
MDR-KP)
are
significant
public
health
threats.
This
study
aimed
to
isolate
a
lytic
bacteriophage
targeting
these
high-risk
strains,
systematically
characterize
its
biological
properties,
genomic
features,
therapeutic
efficacy,
establish
foundation
for
clinical
phage
therapy
novel
antimicrobial
development.
Methods
The
vB_Kp_XP4
was
isolated
from
river
water
using
the
double-layer
agar
plate
method
with
clinically
strain
P4
as
host.
Morphology
analyzed
via
transmission
electron
microscopy
(TEM).
Host
range,
pH,
thermal
stability
were
assessed
spot
assays
OD
630
measurements.
One-step
growth
curves
determined
latent
period
burst
size.
Whole-genome
sequencing
phylogenetic
analysis
performed.
Therapeutic
efficacy
safety
evaluated
in
Galleria
mellonella
infection
model.
Results
TEM
revealed
Phage
tailed
an
icosahedral
head
long,
flexible
tail.
It
lysed
hvKP
(carrying
rmp
,
peg
iuc
iro
genes)
MDR-KP
(resistant
carbapenems,
fluoroquinolones,
etc.),
optimal
MOI
of
0.1
<10
minutes.
Stability
maintained
at
pH
4–11
≤70°C.
linear
double-stranded
DNA
genome
44,344
bp
G+C
content
53.80%.
comprised
54
coding
sequences
lacked
lysogenic,
virulence,
or
antibiotic
resistance
genes.
Phylogenetic
positioned
species
within
genus
Drulisvirus
family
Autographiviridae
.
In
model,
prolonged
survival
P4-infected
larvae
(
P
<
0.001)
Conclusion
exhibits
high
stability,
specificity,
potent
activity,
no
undesirable
genes,
demonstrating
effective
vivo
suggest
potential
applications
against
infections.
presence
multiple
halos
during
plaque
formation
further
enhances
research
value.
complete
sequence
has
been
submitted
GenBank
under
accession
number
PP663283.
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
376, P. 949 - 960
Published: Nov. 6, 2024
Infection
by
multidrug-resistant
(MDR)
bacteria
has
become
one
of
the
biggest
threats
to
public
health
worldwide.
One
reason
for
difficulty
in
treatment
is
lack
proper
delivery
strategies
into
MDR
bacterial
biofilms,
where
thick
extracellular
polymeric
substance
(EPS)
layer
impedes
penetration
antibiotics
and
nanoparticles.
Here,
we
propose
a
novel
bioactive
nanoconjugate
drug-loaded
liposomes
bacteriophages
targeted
eradication
biofilms
orthopedic
infections.
Phage
Sb-1,
which
ability
degrade
EPS,
was
conjugated
with
antibiotic-loaded
liposomes.
Upon
encountering
biofilm,
phage
Sb-1
degrades
EPS
structure,
thereby
increasing
sensitivity
allowing
penetrate
deeply
biofilm.
As
result,
effective
removal
biofilm
achieved
low
dose
antibiotics,
proved
this
study
both
vitro
vivo
investigations.
Notably,
rat
prosthetic
joint
infection
(PJI)
model,
found
that
liposome-phage
nanoconjugates
could
effectively
decrease
load
infected
area
significantly
promote
osteomyelitis
recovery.
It
therefore
believed
conjugation
bacteriophage
open
new
possibilities
infections,
possibly
other
infections
deep
tissues.
Viruses,
Journal Year:
2025,
Volume and Issue:
17(1), P. 123 - 123
Published: Jan. 17, 2025
Phage
therapy
is
experiencing
renewed
interest,
particularly
for
antibiotic-resistant
infections,
and
may
also
be
useful
difficult-to-treat
cases
where
surgery
to
remove
foreign
infected
material
deemed
too
risky.
We
report
a
case
of
recurrent
Pseudomonas
aeruginosa
endocarditis
with
Bentall
infection
treated
successfully
combination
antibiotics
phages.
Journal of Antimicrobial Chemotherapy,
Journal Year:
2024,
Volume and Issue:
79(11), P. 2742 - 2749
Published: Sept. 13, 2024
Abstract
Phage
therapy
is
a
highly
promising
approach
to
address
the
challenge
that
presented
by
global
burden
of
antimicrobial
resistance.
Given
natural
specificity
phages,
phage
susceptibility
testing
(PST)
prerequisite
for
successful
personalized
therapy,
allowing
selection
active
phages
from
large
and
diverse
collections.
However,
issue
an
easy-to-use
standardized
technique
remains.
In
this
review,
we
describe
principles,
advantages
drawbacks
two
routinely
used
PST
techniques:
plaque
growth
kinetic
assays.
These
are
labour-intensive
time-consuming
methods
require
automation
one
or
more
steps,
including
preparation
test
panels,
incubation,
reading
analysis
results.
addition
automation,
there
urgent
need
establish
reference
method
enable
efficient
techniques
therapeutic
phages.
We
discuss
knowledge
gaps
parameters
be
investigated
work
towards
goal.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 7, 2024
Phage
therapy
is
a
promising
antibacterial
strategy,
especially
given
that
drug-resistant
bacterial
infections
are
escalating
worldwide.
Because
phages
not
active
against
all
strains
of
species,
being
considered
for
therapeutic
use
would
ideally
be
tested
isolates
from
individual
patients
prior
to
administration.
Standardized,
clinically
validated
phage
susceptibility
testing
(PST)
methods
needed
assessing
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 27, 2024
When
bacteria
are
treated
with
multiple
antibiotics
simultaneously,
resistance
is
exceedingly
unlikely
to
evolve.
In
stark
contrast,
against
phages
frequently
arises
during
therapy.
Why
does
multi-phage
cocktails
evolve
so
easily?
Using
a
mathematical
model,
we
show
how
the
bacterial
evolutionary
dynamics
and
phage
replicative
uniquely
intertwine,
facilitating
rapid
evolution
of
resistance.
As
different
replicate
become
inhibitory
at
varying
time
points,
can
sequentially
acquire
rather
than
simultaneously
–
increasing
chance
multi-resistance
by
orders
magnitude.
Additionally,
identify
regime
where
robustly
prevented.
Our
findings
provide
framework
for
rational
design
minimize
development.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1879 - 1879
Published: Dec. 4, 2024
As
natural
predators
of
bacteria,
tailed
bacteriophages
can
be
used
in
biocontrol
applications,
including
antimicrobial
therapy.
Also,
phage
lysis
is
a
detrimental
factor
technological
processes
based
on
bacterial
growth
and
metabolism.
The
spectrum
bacteria
interact
with
known
as
the
host
range.
Phage
science
produced
vast
amount
range
data.
However,
there
has
been
no
attempt
to
analyse
these
data
from
viewpoint
modern
taxonomy.
Here,
we
performed
meta-analysis
spotting
plaquing
obtained
strains
production
species.
main
metric
our
study
was
value
calculated
ratio
lysed
number
tested
strains.
We
found
boundary
between
narrow
broad
ranges
phages
taken
whole.
Family-level
groups
strictly
lytic
had
significantly
different
median
values
0.18
(Drexlerviridae)
0.70
(Herelleviridae).
In
Escherichia
coli
phages,
were
associated
decreased
efficiency
plating.
Bacteriophage
morphology,
genome
size,
tRNA-coding
genes
genomes
did
not
correlate
values.
From
perspective
species,
varied
0.04
infecting
Acinetobacter
baumannii
0.73
Staphylococcus
aureus
phages.
Taken
together,
results
imply
that
taxonomy
their
hosts
predictive
intraspecies
ranges.
Virus Research,
Journal Year:
2024,
Volume and Issue:
350, P. 199481 - 199481
Published: Oct. 20, 2024
Klebsiella
pneumoniae
is
a
common,
conditionally
pathogenic
bacterium
that
often
has
multidrug-resistant
phenotype,
leading
to
failure
of
antibiotic
therapies.
It
can
therefore
induce
serious
diseases,
including
community-acquired
pneumonia
and
bloodstream
infections.
As
an
emerging
alternative
antibiotics,
phages
are
considered
key
solving
the
problem
drug-resistant
bacterial
Here,
we
report
novel
phage,
pK3-24,
mainly
targets
ST447
K.
pneumoniae.
Phage
pK3-24
T7-like
short-tailed
phage
with
fast
adsorption
capacity
forms
translucent
plaques
halos
on
lawns.
The
optimal
multiplicity
infection
(MOI)
0.01,
average
burst
size
50
PFU/mL.
shows
environmental
stability,
surviving
at
below
°C
pH
values
6-10.
double-stranded
DNA
genome
40,327
bp
carries
no
antibiotic-resistance,
virulence,
or
lysogeny
genes.
Phylogenetic
analysis
assigned
genus
Przondovirus
as
new
species.
inhibited
production
biofilm.
Moreover,
treatment
doses
MOI
>
1
effectively
reduced
mortality
Galleria
mellonella
larvae
infected
PHAGE,
Journal Year:
2024,
Volume and Issue:
5(4), P. 186 - 202
Published: Oct. 24, 2024
The
escalating
global
threat
of
antibiotic
resistance
has
prompted
a
critical
need
for
innovative
approaches
to
bacterial
infection
treatment.
In
terms
management,
bacterial-associated
disorders
have
reached
point
in
the
world
due
advent
drug-resistant
types
bacteria.
Nonetheless,
continued
bacteriophage
research
presents
promising
frontier
battle
against
infections.
this
study,
we
explored
effectiveness
therapy
antibiotic-resistant
According
our
viewpoint,
phage
could
replace
antibiotics
safety,
efficacy,
and
specificity.
Furthermore,
offers
versatility
administering
single
phage,
products,
or
modified
various
resistant
Moreover,
Phage
cocktails,
with
their
synergistic
combinations,
showcase
holistic
approach,
mitigating
risk
expanding
treatment
possibilities.
Similarly,
synergy
between
phages
holds
promise
overcoming
forging
path
toward
more
effective
sustainable
antimicrobial
strategies.
review
provides
insights
into
transformative
impact
on
current
paradigms,
its
application
methodological
challenges
limitations,
as
well
scientists
policymakers
best
areas
study
order
combat
resistance.